Library

Protocol

TB-500 (5mg Vial)

Complete dosage protocol and reconstitution guide for TB-500 (5mg Vial).

Updated November 27, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismTB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] . This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for accurate insulin‑syringe measurements in research settings.
Dosing500–1000 mcg once daily (gradual titration recommended).
ReconstitutionAdd 3.0 mL diluent to a 5 mg vial.
StorageLyophilized: store at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; do not freeze reconstituted solution.

Calculator preset

Run the vial math before tracking.

At ~1.67 mg/mL, 1 unit ~ 16.7 mcg ; 500 mcg ~ 30 units and 1000 mcg ~ 60 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] . This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for accurate insulin‑syringe measurements in research settings.

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.
Reference dose500–1000 mcg once daily (gradual titration recommended).
Easy measuringAt ~1.67 mg/mL, 1 unit ~ 16.7 mcg ; 500 mcg ~ 30 units and 1000 mcg ~ 60 units on a U-100 syringe.
StorageLyophilized: store at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; do not freeze reconstituted solution.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–2500 mcg30 units (0.30 mL)
Weeks 3–4600 mcg36 units (0.36 mL)
Weeks 5–8750 mcg45 units (0.45 mL)
Weeks 9–121000 mcg60 units (0.60 mL)

500–1000 mcg once daily (gradual titration recommended).

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label with date and concentration; refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks ≈ 8 vials
  • 12 weeks ≈ 12 vials
  • 16 weeks ≈ 16 vials
Insulin Syringes Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
  • 16 weeks: 112 syringes
Bacteriostatic Water Use ~3.0 mL per vial for reconstitution.
  • 8 weeks (8 vials): 24 mL → 3 × 10 mL bottles
  • 12 weeks (12 vials): 36 mL → 4 × 10 mL bottles
  • 16 weeks (16 vials): 48 mL → 5 × 10 mL bottles
Alcohol Swabs One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
  • 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

  • Goal: Support tissue repair, wound healing, and angiogenesis through the active thymosin beta‑4 fragment mechanism [5] [6] .
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if research goals require).
  • Dose Range: 500–1000 mcg daily with gradual titration (~5 mg/week average).
  • Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid freeze–thaw cycles of reconstituted solution.

Dosing Protocol

  • Suggested daily titration approach.
  • Start: 500 mcg daily; increase by ~100–150 mcg every 2 weeks as tolerated.
  • Target: 750–1000 mcg daily by Weeks 5–12.
  • Frequency: Once per day (subcutaneous).
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks based on research protocol.
  • Timing: Any consistent time daily; rotate injection sites systematically.

Storage Instructions

  • Lyophilized: store at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; do not freeze reconstituted solution.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid freeze–thaw cycles of reconstituted solution.
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency and safety in research protocols.
  • Use new sterile insulin syringes for each injection; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and lipohypertrophy [9] .
  • Inject slowly; wait a few seconds before withdrawing the needle to prevent backflow.
  • Document daily dose, injection site, and any observations to maintain consistency.
  • Regulatory Note: TB‑500 is banned by WADA for athletic use and is not FDA‑approved for human administration [10] .

05 · How it works

How This Works

TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] .

This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for accurate insulin‑syringe measurements in research settings.

Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • TB-500 observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching